U.S. Vaccine Program Now Flush With Cash, but Short on Key Details
Efforts to develop the next generation of Covid vaccines are running up against bureaucratic hassles and regulatory uncertainty, scientists say, obstacles that could make it harder to curb the spread of the coronavirus and arm the United States against future pandemics. The Biden administration, after months of delay, has now addressed at least a shortfall…
Details